Milligan Michael Lee

Insider profile

Milligan Michael Lee's trades of Neumora Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-19 2026-02-17 PlS Planned sale
68,290 +2.1%
235.25
US$4,569,221
68,290 +2.1% 235.25 US$4,569,221
2026-02-17 2026-02-17 PrS Proposed sale
77,380
183.48
US$794,511
77,380 183.48 US$794,511
2025-02-20 2025-02-18 PlS Planned sale
95,025 +10.2%
234.11
US$2,714,856
95,025 +10.2% 234.11 US$2,714,856
2025-02-18 2025-02-18 PrS Proposed sale
1,978
1.69
US$3,351
1,978 1.69 US$3,351